Le Lézard
Classified in: Health

Intellijoint Surgical Eager to Expand OEM Business with New Robotic and Navigation Partners

Kitchener, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Intellijoint Surgical congratulates Accelus for being listed in Bonezone's 5 Orthopedic Companies to Watch in 2023 "because of consistent growth through development deals, the gathering of clinical evidence to back novel treatment solutions and active portfolios supported by numerous product launches." Accelus experienced impressive growth in 2022 through the Remi Robotic Navigation System and their FlareHawk portfolio of multidirectional expandable implants.


Intellijoint's relationship with Accelus and their Remi Robotic Navigation System, a navigated robotic targeting system for spine surgery, began in 2020. Remi utilizes Intellijoint's camera as an integral component of the system to provide enhanced line of sight and enable close positioning while tracking instruments with a broader range than other conventional systems. Remi's simplified workflow and small footprint make this innovative system appealing to surgeons, saving them OR setup and planning time.1


Intellijoint's camera fills a void in the market offering reduced setup time, miniaturized OR footprint, full control from within the sterile field and no line-of-sight issues. While Intellijoint remains firmly committed to innovating in hip and knee arthroplasty, carrying the clinical pedigree of the camera into spine was a natural fit.  


"Intellijoint Surgical had the camera solution we needed to bring our innovative spine robotic navigation platform to market," said, Brad Clayton, Accelus Chief Technology Officer.  "Remi is the perfect complement to our robust portfolio of enabling implants, instruments, and technologies that allow surgeons to simply address complex pathology, as well as our new product pipeline designed to easily solve clinical challenges of spine through innovation."


Intellijoint celebrates the resounding success of Accelus and innovation in navigated robotics and is actively seeking finished device makers as new partners to further benefit patients and the robotics and surgical navigation industries globally through its new venture- IJX. For more information, contact: info@ijxnavigation.com


1. Soliman M A, Khan A, O'Connor T E, et al. (June 26, 2021) Accuracy and Efficiency of Fusion Roboticstm Versus Mazor-Xtm in Single-Level Lumbar Pedicle Screw Placement. Cureus 13(6): e15939. doi:10.7759/cureus.15939



About Intellijoint Surgical

 Intellijoint Surgical® develops and commercializes surgical planning & navigation solutions for total hip and knee joint replacements, as well as digital patient engagement for all orthopaedic specialties. It is committed to improving patients' lives by providing every surgeon with effective, easy-to-use technology to manage the entire episode of care. Intellijoint's technology is used by top orthopaedic institutions and surgeons globally. For more information on Intellijoint Surgical visit www.intellijointsurgical.com

About IJX

IJX partners with finished device makers to develop miniature optical tracking technology for 3D localization in health technology applications globally. IJX provides small footprint optical tracking for surgical navigation and robotics with customization available for several applications with consistent accuracy and user experience. IJX is committed to advancing healthcare technology to benefit patients globally with exceptional outcomes.For more information visit www.ijxnavigation.com


About Accelus

Accelus is committed to accelerating minimally invasive spine surgery through its enabling technology with broad accessibility to previously underserved markets. Established in 2021 through the combination of Integrity Implants and Fusion Robotics, the company is focused on providing its proprietary Adaptive Geometrytm technology with pragmatic and economical navigation and robotic solutions with broad clinical use in spine surgery. Learn more at www.accelusinc.com.


These press releases may also interest you

at 11:35
Dr.Evidence is pleased to announce the appointment of Ken Kobayashi, MD, FACP to the MSAB. He joins Chair, Calum MacRae, MB, ChB, PhD, BSc, and members, Michael Klag, MD, MPH, Frank Rockhold, PhD, ScM, BA, and David Tovey, MD. Dr. Kobayashi has a...

at 11:22
In the United States, Alzheimer's disease affects more than six million Americans and more than 11 million provide unpaid care for people with Alzheimer's or other dementias. There's now growing evidence that peanuts can help address this disease by...

at 11:20
PharmaJet,® a company engineering Precision Delivery Systemstm that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that Marie Mazur, PharmD, has been appointed Chair of the Board of Directors. She replaces Ron Lowy...

at 11:17
NKILT Therapeutics, a new biotech company committed to the development of novel natural killer (NK) cell therapies, announced today the appointment to their Scientific Advisory Board (SAB) of Saar Gill, MD, PhD, as Chairman and Maksim Mamonkin, PhD,...

at 11:15
This year, more than 1,000 people participated in the 24th Annual Best Buddies Challenge: Hyannis Port presented by Shaw's and Star Market Foundation and The TJX Companies, Inc., a cycling, run and walk fundraiser from Boston to Hyannis Port, on June...

at 11:08
Kate Farms® the market leader bringing plant-based nutrition into healthcare, today announced the appointment of Daniel Welch to the post of Chief Financial Officer. Welch joins Kate Farms from Oura Health, maker of the Oura Ring, where he was Chief...

News published on and distributed by: